ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 171 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $85,832 | -29.5% | 87,584 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $121,741 | -12.6% | 87,584 | 0.0% | 0.00% | -50.0% |
| Q1 2023 | $139,258 | -74.4% | 87,584 | +0.2% | 0.00% | -66.7% |
| Q4 2022 | $544,402 | -44.0% | 87,384 | -39.8% | 0.01% | -40.0% |
| Q3 2022 | $973,000 | -12.8% | 145,245 | -17.3% | 0.01% | -9.1% |
| Q2 2022 | $1,116,000 | +32.5% | 175,669 | -3.3% | 0.01% | +37.5% |
| Q1 2022 | $842,000 | +10.2% | 181,701 | +18.8% | 0.01% | +14.3% |
| Q4 2021 | $764,000 | -46.0% | 152,932 | +30.2% | 0.01% | -41.7% |
| Q3 2021 | $1,415,000 | -12.2% | 117,500 | +54.2% | 0.01% | 0.0% |
| Q2 2021 | $1,611,000 | +4781.8% | 76,200 | +6250.0% | 0.01% | – |
| Q1 2021 | $33,000 | – | 1,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 2,679,835 | $69,675,000 | 19.39% |
| Endurant Capital Management LP | 207,293 | $5,390,000 | 1.94% |
| Bellevue Group AG | 5,138,451 | $133,599,000 | 1.53% |
| Rhenman & Partners Asset Management AB | 592,225 | $15,398,000 | 1.26% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,562,869 | $40,635,000 | 0.93% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 31,434 | $817,000 | 0.62% |
| WASATCH ADVISORS LP | 3,998,010 | $103,949,000 | 0.51% |
| HAMILTON LANE ADVISORS LLC | 46,181 | $1,201,000 | 0.45% |
| Boxer Capital, LLC | 500,000 | $13,000,000 | 0.42% |
| DCF Advisers, LLC | 38,500 | $1,001,000 | 0.41% |